{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:29:49Z","timestamp":1770488989080,"version":"3.49.0"},"publisher-location":"Cham","reference-count":146,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319717784","type":"print"},{"value":"9783319717791","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-71779-1_18","type":"book-chapter","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T09:51:01Z","timestamp":1518169861000},"page":"349-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis"],"prefix":"10.1007","author":[{"given":"Cl\u00e9vio","family":"N\u00f3brega","sequence":"first","affiliation":[]},{"given":"Ana Teresa","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Duarte-Neves","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Vasconcelos-Ferreira","sequence":"additional","affiliation":[]},{"given":"Janete","family":"Cunha-Santos","sequence":"additional","affiliation":[]},{"given":"Dina","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Magda","family":"Santana","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia","family":"Cavadas","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds Pereira","family":"de Almeida","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ana.410410408","volume":"41","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Das SS, Crino PB, Perez MK, Patel SC, Gotsdiner D, Fischbeck KH, Pittman RN (1997) Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 41:453\u2013462","journal-title":"Ann Neurol"},{"key":"18_CR2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1750-3639.1998.tb00193.x","volume":"8","author":"T Schmidt","year":"1998","unstructured":"Schmidt T et al (1998) An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol 8:669\u2013679","journal-title":"Brain Pathol"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(03)00748-8","volume":"549","author":"L Masino","year":"2003","unstructured":"Masino L, Musi V, Menon RP, Fusi P, Kelly G, Frenkiel TA, Trottier Y, Pastore A (2003) Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail. FEBS Lett 549:21\u201325","journal-title":"FEBS Lett"},{"key":"18_CR4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nsmb1215","volume":"14","author":"Y Nagai","year":"2007","unstructured":"Nagai Y, Inui T, Popiel HA, Fujikake N, Hasegawa K, Urade Y, Goto Y, Naiki H, Toda T (2007) A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol 14:332\u2013340","journal-title":"Nat Struct Mol Biol"},{"key":"18_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","volume":"19","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19:333\u2013344","journal-title":"Neuron"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","volume":"27","author":"U Bichelmeier","year":"2007","unstructured":"Bichelmeier U et al (2007) Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci 27:7418\u20137428","journal-title":"J Neurosci"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/hmg\/11.23.2905","volume":"11","author":"W Yang","year":"2002","unstructured":"Yang W, Dunlap JR, Andrews RB, Wetzel R (2002) Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet 11:2905\u20132917","journal-title":"Hum Mol Genet"},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nbd.2009.08.002","volume":"37","author":"J Boy","year":"2010","unstructured":"Boy J et al (2010) A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats. Neurobiol Dis 37:284\u2013293","journal-title":"Neurobiol Dis"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2010.05.021","volume":"40","author":"A Silva-Fernandes","year":"2010","unstructured":"Silva-Fernandes A et al (2010) Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products. Neurobiol Dis 40:163\u2013176","journal-title":"Neurobiol Dis"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/nbdi.1998.0208","volume":"5","author":"Y Trottier","year":"1998","unstructured":"Trottier Y, Cancel G, An-Gourfinkel I, Lutz Y, Weber C, Brice A, Hirsch E, Mandel JL (1998) Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol Dis 5:335\u2013347","journal-title":"Neurobiol Dis"},{"key":"18_CR11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)81200-3","volume":"93","author":"JM Warrick","year":"1998","unstructured":"Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN, Bonini NM (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93:939\u2013949","journal-title":"Cell"},{"key":"18_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pneurobio.2011.06.007","volume":"95","author":"CA Matos","year":"2011","unstructured":"Matos CA, de Macedo-Ribeiro S, Carvalho AL (2011) Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Prog Neurobiol 95:26\u201348","journal-title":"Prog Neurobiol"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","volume":"97","author":"C Costa Mdo","year":"2012","unstructured":"Costa Mdo C, Paulson HL (2012) Toward understanding Machado-Joseph disease. Prog Neurobiol 97:239\u2013257","journal-title":"Prog Neurobiol"},{"key":"18_CR14","first-page":"1513","volume":"49","author":"MM Evers","year":"2014","unstructured":"Evers MM, Toonen LJ, van Roon-Mom WM (2014) Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol Neurobiol 49:1513\u20131531","journal-title":"Mol Neurobiol"},{"key":"18_CR15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pediatrneurol.2007.12.006","volume":"38","author":"DR Carvalho","year":"2008","unstructured":"Carvalho DR, La Rocque-Ferreira A, Rizzo IM, Imamura EU, Speck-Martins CE (2008) Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol 38:296\u2013299","journal-title":"Pediatr Neurol"},{"key":"18_CR16","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1096\/fj.06-7002com","volume":"21","author":"AJ Rodrigues","year":"2007","unstructured":"Rodrigues AJ, Coppola G, Santos C, Costa Mdo C, Ailion M, Sequeiros J, Geschwind DH, Maciel P (2007) Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. FASEB J 21:1126\u20131136","journal-title":"FASEB J"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","volume":"362","author":"I Schmitt","year":"2007","unstructured":"Schmitt I, Linden M, Khazneh H, Evert BO, Breuer P, Klockgether T, Wuellner U (2007) Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem Biophys Res Commun 362:734\u2013739","journal-title":"Biochem Biophys Res Commun"},{"key":"18_CR18","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1523\/JNEUROSCI.19-23-10338.1999","volume":"19","author":"Y Chai","year":"1999","unstructured":"Chai Y, Koppenhafer SL, Bonini NM, Paulson HL (1999) Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J Neurosci 19:10338\u201310347","journal-title":"J Neurosci"},{"key":"18_CR19","doi-asserted-by":"crossref","first-page":"44889","DOI":"10.1074\/jbc.M106575200","volume":"276","author":"Y Chai","year":"2001","unstructured":"Chai Y, Wu L, Griffin JD, Paulson HL (2001) The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J Biol Chem 276:44889\u201344897","journal-title":"J Biol Chem"},{"key":"18_CR20","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","volume":"9","author":"A McCampbell","year":"2000","unstructured":"McCampbell A et al (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9:2197\u20132202","journal-title":"Hum Mol Genet"},{"key":"18_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ng0696-196","volume":"13","author":"H Ikeda","year":"1996","unstructured":"Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A (1996) Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet 13:196\u2013202","journal-title":"Nat Genet"},{"key":"18_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/9.1.69","volume":"9","author":"T Yoshizawa","year":"2000","unstructured":"Yoshizawa T, Yamagishi Y, Koseki N, Goto J, Yoshida H, Shibasaki F, Shoji S, Kanazawa I (2000) Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch. Hum Mol Genet 9:69\u201378","journal-title":"Hum Mol Genet"},{"key":"18_CR23","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1523\/JNEUROSCI.2734-04.2004","volume":"24","author":"D Goti","year":"2004","unstructured":"Goti D et al (2004) A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci 24:10266\u201310279","journal-title":"J Neurosci"},{"key":"18_CR24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/brain\/awr118","volume":"134","author":"J Hubener","year":"2011","unstructured":"Hubener J et al (2011) N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation. Brain 134:1925\u20131942","journal-title":"Brain"},{"key":"18_CR25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1471-4159.2004.02369.x","volume":"89","author":"SJ Berke","year":"2004","unstructured":"Berke SJ, Schmied FA, Brunt ER, Ellerby LM, Paulson HL (2004) Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J Neurochem 89:908\u2013918","journal-title":"J Neurochem"},{"key":"18_CR26","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1074\/jbc.M109.036335","volume":"285","author":"P Breuer","year":"2010","unstructured":"Breuer P, Haacke A, Evert BO, Wullner U (2010) Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control. J Biol Chem 285:6532\u20136537","journal-title":"J Biol Chem"},{"key":"18_CR27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/hmg\/ddi472","volume":"15","author":"A Haacke","year":"2006","unstructured":"Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, Breuer P (2006) Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum Mol Genet 15:555\u2013568","journal-title":"Hum Mol Genet"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1093\/hmg\/ddp456","volume":"18","author":"J Jung","year":"2009","unstructured":"Jung J, Xu K, Lessing D, Bonini NM (2009) Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3. Hum Mol Genet 18:4843\u20134852","journal-title":"Hum Mol Genet"},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/jnc.12684","volume":"129","author":"J Liman","year":"2014","unstructured":"Liman J, Deeg S, Voigt A, Vossfeldt H, Dohm CP, Karch A, Weishaupt J, Schulz JB, Bahr M, Kermer P (2014) CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration. J Neurochem 129:1013\u20131023","journal-title":"J Neurochem"},{"key":"18_CR30","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","volume":"273","author":"CL Wellington","year":"1998","unstructured":"Wellington CL et al (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158\u20139167","journal-title":"J Biol Chem"},{"key":"18_CR31","doi-asserted-by":"crossref","first-page":"18851","DOI":"10.1074\/jbc.M611914200","volume":"282","author":"A Haacke","year":"2007","unstructured":"Haacke A, Hartl FU, Breuer P (2007) Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3. J Biol Chem 282:18851\u201318856","journal-title":"J Biol Chem"},{"key":"18_CR32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/hmg\/dds449","volume":"22","author":"J Hubener","year":"2013","unstructured":"Hubener J et al (2013) Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3). Hum Mol Genet 22:508\u2013518","journal-title":"Hum Mol Genet"},{"key":"18_CR33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature10671","volume":"480","author":"P Koch","year":"2011","unstructured":"Koch P et al (2011) Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Nature 480:543\u2013546","journal-title":"Nature"},{"key":"18_CR34","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/aws177","volume":"135","author":"AT Simoes","year":"2012","unstructured":"Simoes AT, Goncalves N, Koeppen A, Deglon N, Kugler S, Duarte CB, Pereira de Almeida L (2012) Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease. Brain 135:2428\u20132439","journal-title":"Brain"},{"key":"18_CR35","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1093\/hmg\/ddu209","volume":"23","author":"AT Simoes","year":"2014","unstructured":"Simoes AT, Goncalves N, Nobre RJ, Duarte CB, Pereira de Almeida L (2014) Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease. Hum Mol Genet 23:4932\u20134944","journal-title":"Hum Mol Genet"},{"key":"18_CR36","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","volume":"28","author":"X Chen","year":"2008","unstructured":"Chen X, Tang TS, Tu H, Nelson O, Pook M, Hammer R, Nukina N, Bezprozvanny I (2008) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J Neurosci 28:12713\u201312724","journal-title":"J Neurosci"},{"key":"18_CR37","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington\u2019s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A 98:12784\u201312789","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.nbd.2007.06.005","volume":"27","author":"VF Colomer Gould","year":"2007","unstructured":"Colomer Gould VF, Goti D, Pearce D, Gonzalez GA, Gao H, Bermudez de Leon M, Jenkins NA, Copeland NG, Ross CA, Brown DR (2007) A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice. Neurobiol Dis 27:362\u2013369","journal-title":"Neurobiol Dis"},{"key":"18_CR39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2009.07.020","volume":"36","author":"PM Antony","year":"2009","unstructured":"Antony PM, Mantele S, Mollenkopf P, Boy J, Kehlenbach RH, Riess O, Schmidt T (2009) Identification and functional dissection of localization signals within ataxin-3. Neurobiol Dis 36:280\u2013292","journal-title":"Neurobiol Dis"},{"key":"18_CR40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/ddh005","volume":"13","author":"S Chen","year":"2004","unstructured":"Chen S, Peng GH, Wang X, Smith AC, Grote SK, Sopher BL, La Spada AR (2004) Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization. Hum Mol Genet 13:53\u201367","journal-title":"Hum Mol Genet"},{"key":"18_CR41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","volume":"15","author":"H Goehler","year":"2004","unstructured":"Goehler H et al (2004) A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington\u2019s disease. Mol Cell 15:853\u2013865","journal-title":"Mol Cell"},{"key":"18_CR42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2006.03.032","volume":"125","author":"J Lim","year":"2006","unstructured":"Lim J et al (2006) A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125:801\u2013814","journal-title":"Cell"},{"key":"18_CR43","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2005.06.012","volume":"122","author":"H Tsuda","year":"2005","unstructured":"Tsuda H et al (2005) The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1\/senseless proteins. Cell 122:633\u2013644","journal-title":"Cell"},{"key":"18_CR45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jmcb\/mjq005","volume":"2","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Katada S, Onodera O (2010) Polyglutamine diseases: where does toxicity come from? what is toxicity? where are we going? J Mol Cell Biol 2:180\u2013191","journal-title":"J Mol Cell Biol"},{"key":"18_CR46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004010100364","volume":"102","author":"T Uchihara","year":"2001","unstructured":"Uchihara T, Fujigasaki H, Koyano S, Nakamura A, Yagishita S, Iwabuchi K (2001) Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias\u2013triple-labeling immunofluorescence study. Acta Neuropathol 102:149\u2013152","journal-title":"Acta Neuropathol"},{"key":"18_CR47","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/brain\/awv298","volume":"138","author":"C Nobrega","year":"2015","unstructured":"Nobrega C, Carmo-Silva S, Albuquerque D, Vasconcelos-Ferreira A, Vijayakumar UG, Mendonca L, Hirai H, de Almeida LP (2015) Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease. Brain 138:3537\u20133554","journal-title":"Brain"},{"key":"18_CR48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1242\/jcs.090985","volume":"125","author":"MJ Clague","year":"2012","unstructured":"Clague MJ, Coulson JM, Urbe S (2012) Cellular functions of the DUBs. J Cell Sci 125:277\u2013286","journal-title":"J Cell Sci"},{"key":"18_CR49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tcb.2013.12.003","volume":"24","author":"G Kleiger","year":"2014","unstructured":"Kleiger G, Mayor T (2014) Perilous journey: a tour of the ubiquitin-proteasome system. Trends Cell Biol 24:352\u2013359","journal-title":"Trends Cell Biol"},{"key":"18_CR50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","volume":"78","author":"FE Reyes-Turcu","year":"2009","unstructured":"Reyes-Turcu FE, Ventii KH, Wilkinson KD (2009) Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78:363\u2013397","journal-title":"Annu Rev Biochem"},{"key":"18_CR51","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/cdd.2016.53","volume":"23","author":"B Suresh","year":"2016","unstructured":"Suresh B, Lee J, Kim H, Ramakrishna S (2016) Regulation of pluripotency and differentiation by deubiquitinating enzymes. Cell Death Differ 23:1257\u20131264","journal-title":"Cell Death Differ"},{"key":"18_CR52","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.3029875","volume":"235","author":"H Mori","year":"1987","unstructured":"Mori H, Kondo J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer\u2019s disease. Science 235:1641\u20131644","journal-title":"Science"},{"key":"18_CR53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2004.07.131","volume":"322","author":"MK Chow","year":"2004","unstructured":"Chow MK, Mackay JP, Whisstock JC, Scanlon MJ, Bottomley SP (2004) Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Biochem Biophys Res Commun 322:387\u2013394","journal-title":"Biochem Biophys Res Commun"},{"key":"18_CR54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/502","volume":"19","author":"CJ Cummings","year":"1998","unstructured":"Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 19:148\u2013154","journal-title":"Nat Genet"},{"key":"18_CR55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ana.10101","volume":"51","author":"T Schmidt","year":"2002","unstructured":"Schmidt T, Lindenberg KS, Krebs A, Schols L, Laccone F, Herms J, Rechsteiner M, Riess O, Landwehrmeyer GB (2002) Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol 51:302\u2013310","journal-title":"Ann Neurol"},{"key":"18_CR56","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/hmg\/10.22.2569","volume":"10","author":"C Zander","year":"2001","unstructured":"Zander C, Takahashi J, El Hachimi KH, Fujigasaki H, Albanese V, Lebre AS, Stevanin G, Duyckaerts C, Brice A (2001) Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3. Hum Mol Genet 10:2569\u20132579","journal-title":"Hum Mol Genet"},{"key":"18_CR57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-010-0717-7","volume":"120","author":"K Seidel","year":"2010","unstructured":"Seidel K, den Dunnen WF, Schultz C, Paulson H, Frank S, de Vos RA, Brunt ER, Deller T, Kampinga HH, Rub U (2010) Axonal inclusions in spinocerebellar ataxia type 3. Acta Neuropathol 120:449\u2013460","journal-title":"Acta Neuropathol"},{"key":"18_CR58","doi-asserted-by":"crossref","first-page":"32026","DOI":"10.1074\/jbc.M506084200","volume":"280","author":"SJ Berke","year":"2005","unstructured":"Berke SJ, Chai Y, Marrs GL, Wen H, Paulson HL (2005) Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem 280:32026\u201332034","journal-title":"J Biol Chem"},{"key":"18_CR59","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1073\/pnas.0506344102","volume":"102","author":"Y Mao","year":"2005","unstructured":"Mao Y, Senic-Matuglia F, Di Fiore PP, Polo S, Hodsdon ME, De Camilli P (2005) Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. Proc Natl Acad Sci U S A 102:12700\u201312705","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR60","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1073\/pnas.0501732102","volume":"102","author":"G Nicastro","year":"2005","unstructured":"Nicastro G, Menon RP, Masino L, Knowles PP, McDonald NQ, Pastore A (2005) The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc Natl Acad Sci U S A 102:10493\u201310498","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR61","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/hmg\/ddg344","volume":"12","author":"B Burnett","year":"2003","unstructured":"Burnett B, Li F, Pittman RN (2003) The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum Mol Genet 12:3195\u20133205","journal-title":"Hum Mol Genet"},{"key":"18_CR62","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1074\/jbc.M310939200","volume":"279","author":"Y Chai","year":"2004","unstructured":"Chai Y, Berke SS, Cohen RE, Paulson HL (2004) Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem 279:3605\u20133611","journal-title":"J Biol Chem"},{"key":"18_CR63","doi-asserted-by":"crossref","first-page":"26436","DOI":"10.1074\/jbc.M803692200","volume":"283","author":"BJ Winborn","year":"2008","unstructured":"Winborn BJ, Travis SM, Todi SV, Scaglione KM, Xu P, Williams AJ, Cohen RE, Peng J, Paulson HL (2008) The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J Biol Chem 283:26436\u201326443","journal-title":"J Biol Chem"},{"key":"18_CR64","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/sj.emboj.7601043","volume":"25","author":"A Boeddrich","year":"2006","unstructured":"Boeddrich A et al (2006) An arginine\/lysine-rich motif is crucial for VCP\/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J 25:1547\u20131558","journal-title":"EMBO J"},{"key":"18_CR65","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.1530212100","volume":"100","author":"KM Donaldson","year":"2003","unstructured":"Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, Joazeiro CA (2003) Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci U S A 100:8892\u20138897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR66","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/MCB.23.18.6469-6483.2003","volume":"23","author":"EW Doss-Pepe","year":"2003","unstructured":"Doss-Pepe EW, Stenroos ES, Johnson WG, Madura K (2003) Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol Cell Biol 23:6469\u20136483","journal-title":"Mol Cell Biol"},{"key":"18_CR67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/hmg\/ddq452","volume":"20","author":"TM Durcan","year":"2011","unstructured":"Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA (2011) The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet 20:141\u2013154","journal-title":"Hum Mol Genet"},{"key":"18_CR68","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1074\/jbc.M412042200","volume":"280","author":"NR Jana","year":"2005","unstructured":"Jana NR, Dikshit P, Goswami A, Kotliarova S, Murata S, Tanaka K, Nukina N (2005) Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J Biol Chem 280:11635\u201311640","journal-title":"J Biol Chem"},{"key":"18_CR69","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.emboj.7600081","volume":"23","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Yada M, Hatakeyama S, Ishimoto H, Tanimura T, Tsuji S, Kakizuka A, Kitagawa M, Nakayama KI (2004) Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J 23:659\u2013669","journal-title":"EMBO J"},{"key":"18_CR70","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molcel.2011.05.036","volume":"43","author":"KM Scaglione","year":"2011","unstructured":"Scaglione KM et al (2011) Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol Cell 43:599\u2013612","journal-title":"Mol Cell"},{"key":"18_CR71","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1074\/jbc.M212235200","volume":"278","author":"YC Tsai","year":"2003","unstructured":"Tsai YC, Fishman PS, Thakor NV, Oyler GA (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem 278:22044\u201322055","journal-title":"J Biol Chem"},{"key":"18_CR72","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1083\/jcb.200605100","volume":"174","author":"Q Wang","year":"2006","unstructured":"Wang Q, Li L, Ye Y (2006) Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J Cell Biol 174:963\u2013971","journal-title":"J Cell Biol"},{"key":"18_CR73","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1093\/hmg\/ddp380","volume":"18","author":"Z Ying","year":"2009","unstructured":"Ying Z, Wang H, Fan H, Zhu X, Zhou J, Fei E, Wang G (2009) Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum Mol Genet 18:4268\u20134281","journal-title":"Hum Mol Genet"},{"key":"18_CR74","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/hmg\/ddl164","volume":"15","author":"X Zhong","year":"2006","unstructured":"Zhong X, Pittman RN (2006) Ataxin-3 binds VCP\/p97 and regulates retrotranslocation of ERAD substrates. Hum Mol Genet 15:2409\u20132420","journal-title":"Hum Mol Genet"},{"key":"18_CR75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fneur.2013.00046","volume":"4","author":"TM Durcan","year":"2013","unstructured":"Durcan TM, Fon EA (2013) Ataxin-3 and its e3 partners: implications for machado-joseph disease. Front Neurol 4:46","journal-title":"Front Neurol"},{"key":"18_CR76","doi-asserted-by":"crossref","first-page":"e43563","DOI":"10.1371\/journal.pone.0043563","volume":"7","author":"MN Laco","year":"2012","unstructured":"Laco MN, Cortes L, Travis SM, Paulson HL, Rego AC (2012) Valosin-containing protein (VCP\/p97) is an activator of wild-type ataxin-3. PLoS ONE 7:e43563","journal-title":"PLoS ONE"},{"key":"18_CR77","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbadis.2011.10.010","volume":"1822","author":"MN Laco","year":"2012","unstructured":"Laco MN, Oliveira CR, Paulson HL, Rego AC (2012) Compromised mitochondrial complex II in models of Machado-Joseph disease. Biochim Biophys Acta 1822:139\u2013149","journal-title":"Biochim Biophys Acta"},{"key":"18_CR78","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","volume":"292","author":"NF Bence","year":"2001","unstructured":"Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292:1552\u20131555","journal-title":"Science"},{"key":"18_CR79","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.molcel.2009.01.014","volume":"33","author":"ZJ Chen","year":"2009","unstructured":"Chen ZJ, Sun LJ (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33:275\u2013286","journal-title":"Mol Cell"},{"key":"18_CR80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/hmg\/ddu422","volume":"24","author":"A Neves-Carvalho","year":"2015","unstructured":"Neves-Carvalho A et al (2015) Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells. Hum Mol Genet 24:100\u2013117","journal-title":"Hum Mol Genet"},{"key":"18_CR81","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tcb.2003.12.002","volume":"14","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM (2004) Autophagy: in sickness and in health. Trends Cell Biol 14:70\u201377","journal-title":"Trends Cell Biol"},{"key":"18_CR82","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/B:MCBI.0000041848.57020.57","volume":"263","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM (2004) Autophagy: many paths to the same end. Mol Cell Biochem 263:55\u201372","journal-title":"Mol Cell Biochem"},{"key":"18_CR83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0070-2153(06)76003-3","volume":"76","author":"A Williams","year":"2006","unstructured":"Williams A, Jahreiss L, Sarkar S, Saiki S, Menzies FM, Ravikumar B, Rubinsztein DC (2006) Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 76:89\u2013101","journal-title":"Curr Top Dev Biol"},{"key":"18_CR84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","volume":"15","author":"Z Berger","year":"2006","unstructured":"Berger Z et al (2006) Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 15:433\u2013442","journal-title":"Hum Mol Genet"},{"key":"18_CR85","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","volume":"11","author":"B Ravikumar","year":"2002","unstructured":"Ravikumar B, Duden R, Rubinsztein DC (2002) Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11:1107\u20131117","journal-title":"Hum Mol Genet"},{"key":"18_CR86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/awp292","volume":"133","author":"FM Menzies","year":"2010","unstructured":"Menzies FM, Huebener J, Renna M, Bonin M, Riess O, Rubinsztein DC (2010) Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 133:93\u2013104","journal-title":"Brain"},{"key":"18_CR87","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1371\/journal.pgen.0030177","volume":"3","author":"J Bilen","year":"2007","unstructured":"Bilen J, Bonini NM (2007) Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 3:1950\u20131964","journal-title":"PLoS Genet"},{"key":"18_CR88","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awr047","volume":"134","author":"I Nascimento-Ferreira","year":"2011","unstructured":"Nascimento-Ferreira I et al (2011) Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease. Brain 134:1400\u20131415","journal-title":"Brain"},{"key":"18_CR89","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature22078","volume":"545","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC (2017) Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature 545:108\u2013111","journal-title":"Nature"},{"key":"18_CR90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrn2417","volume":"9","author":"AB Knott","year":"2008","unstructured":"Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9:505\u2013518","journal-title":"Nat Rev Neurosci"},{"key":"18_CR91","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646\u2013653","journal-title":"Ann Neurol"},{"key":"18_CR92","doi-asserted-by":"crossref","unstructured":"Lou S, Lepak VC, Eberly LE, Roth B, Cui W, Zhu XH, Oz G, Dubinsky JM (2016) Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress. Hum Mol Genet","DOI":"10.1093\/hmg\/ddw138"},{"key":"18_CR93","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28:2783\u20132792","journal-title":"J Neurosci"},{"key":"18_CR94","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"18_CR95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0361-9230(01)00583-4","volume":"56","author":"AM Beauchemin","year":"2001","unstructured":"Beauchemin AM, Gottlieb B, Beitel LK, Elhaji YA, Pinsky L, Trifiro MA (2001) Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Brain Res Bull 56:285\u2013297","journal-title":"Brain Res Bull"},{"key":"18_CR96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","volume":"48","author":"R Lodi","year":"2000","unstructured":"Lodi R, Schapira AH, Manners D, Styles P, Wood NW, Taylor DJ, Warner TT (2000) Abnormal in vivo skeletal muscle energy metabolism in Huntington\u2019s disease and dentatorubropallidoluysian atrophy. Ann Neurol 48:72\u201376","journal-title":"Ann Neurol"},{"key":"18_CR97","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1471-4159.1999.0720700.x","volume":"72","author":"SJ Kish","year":"1999","unstructured":"Kish SJ, Mastrogiacomo F, Guttman M, Furukawa Y, Taanman JW, Dozic S, Pandolfo M, Lamarche J, DiStefano L, Chang LJ (1999) Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer\u2019s disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? J Neurochem 72:700\u2013707","journal-title":"J Neurochem"},{"key":"18_CR98","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.1996.tb00174.x","volume":"93","author":"T Matsuishi","year":"1996","unstructured":"Matsuishi T, Sakai T, Naito E, Nagamitsu S, Kuroda Y, Iwashita H, Kato H (1996) Elevated cerebrospinal fluid lactate\/pyruvate ratio in Machado-Joseph disease. Acta Neurol Scand 93:72\u201375","journal-title":"Acta Neurol Scand"},{"key":"18_CR99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.nbd.2005.07.011","volume":"21","author":"AH Chou","year":"2006","unstructured":"Chou AH, Yeh TH, Kuo YL, Kao YC, Jou MJ, Hsu CY, Tsai SR, Kakizuka A, Wang HL (2006) Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL. Neurobiol Dis 21:333\u2013345","journal-title":"Neurobiol Dis"},{"key":"18_CR100","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbrc.2004.09.192","volume":"324","author":"HF Tsai","year":"2004","unstructured":"Tsai HF, Tsai HJ, Hsieh M (2004) Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells. Biochem Biophys Res Commun 324:1274\u20131282","journal-title":"Biochem Biophys Res Commun"},{"key":"18_CR101","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/jnr.22011","volume":"87","author":"YC Yu","year":"2009","unstructured":"Yu YC, Kuo CL, Cheng WL, Liu CS, Hsieh M (2009) Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. J Neurosci Res 87:1884\u20131891","journal-title":"J Neurosci Res"},{"key":"18_CR102","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2008.01.011","volume":"30","author":"C Pozzi","year":"2008","unstructured":"Pozzi C, Valtorta M, Tedeschi G, Galbusera E, Pastori V, Bigi A, Nonnis S, Grassi E, Fusi P (2008) Study of subcellular localization and proteolysis of ataxin-3. Neurobiol Dis 30:190\u2013200","journal-title":"Neurobiol Dis"},{"key":"18_CR103","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000339207","volume":"11","author":"N Kazachkova","year":"2013","unstructured":"Kazachkova N, Raposo M, Montiel R, Cymbron T, Bettencourt C, Silva-Fernandes A, Silva S, Maciel P, Lima M (2013) Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of Machado-Joseph disease. Neurodegener Dis 11:206\u2013214","journal-title":"Neurodegener Dis"},{"key":"18_CR104","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12031-014-0360-1","volume":"55","author":"A Ramos","year":"2015","unstructured":"Ramos A, Kazachkova N, Silva F, Maciel P, Silva-Fernandes A, Duarte-Silva S, Santos C, Lima M (2015) Differential mtDNA damage patterns in a transgenic mouse model of Machado-Joseph disease (MJD\/SCA3). J Mol Neurosci 55:449\u2013453","journal-title":"J Mol Neurosci"},{"key":"18_CR105","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1073\/pnas.0610628104","volume":"104","author":"JP Caviston","year":"2007","unstructured":"Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur EL (2007) Huntingtin facilitates dynein\/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A 104:10045\u201310050","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","volume":"40","author":"S Gunawardena","year":"2003","unstructured":"Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, Sintasath L, Bonini NM, Goldstein LS (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40:25\u201340","journal-title":"Neuron"},{"key":"18_CR107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","volume":"40","author":"G Szebenyi","year":"2003","unstructured":"Szebenyi G et al (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40:41\u201352","journal-title":"Neuron"},{"key":"18_CR108","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/jnnp.66.2.222","volume":"66","author":"T Klockgether","year":"1999","unstructured":"Klockgether T et al (1999) Age related axonal neuropathy in spinocerebellar ataxia type 3\/Machado-Joseph disease (SCA3\/MJD). J Neurol Neurosurg Psychiatry 66:222\u2013224","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"18_CR109","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.parkreldis.2009.08.012","volume":"16","author":"A D\u2019Abreu","year":"2010","unstructured":"D\u2019Abreu A, Franca MC Jr, Paulson HL, Lopes-Cendes I (2010) Caring for Machado-Joseph disease: current understanding and how to help patients. Parkinsonism Relat Disord 16:2\u20137","journal-title":"Parkinsonism Relat Disord"},{"key":"18_CR110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrn3531","volume":"14","author":"H Bading","year":"2013","unstructured":"Bading H (2013) Nuclear calcium signalling in the regulation of brain function. Nat Rev Neurosci 14:593\u2013608","journal-title":"Nat Rev Neurosci"},{"key":"18_CR111","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00018-013-1550-7","volume":"71","author":"M Brini","year":"2014","unstructured":"Brini M, Cali T, Ottolini D, Carafoli E (2014) Neuronal calcium signaling: function and dysfunction. Cell Mol Life Sci 71:2787\u20132814","journal-title":"Cell Mol Life Sci"},{"key":"18_CR112","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","volume":"131","author":"DE Clapham","year":"2007","unstructured":"Clapham DE (2007) Calcium signaling. Cell 131:1047\u20131058","journal-title":"Cell"},{"key":"18_CR113","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ceca.2011.03.003","volume":"50","author":"B Zhivotovsky","year":"2011","unstructured":"Zhivotovsky B, Orrenius S (2011) Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium 50:211\u2013221","journal-title":"Cell Calcium"},{"key":"18_CR114","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/j.bbamcr.2013.08.019","volume":"1833","author":"F Pellistri","year":"2013","unstructured":"Pellistri F et al (2013) Different ataxin-3 amyloid aggregates induce intracellular Ca(2+) deregulation by different mechanisms in cerebellar granule cells. Biochim Biophys Acta 1833:3155\u20133165","journal-title":"Biochim Biophys Acta"},{"key":"18_CR115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nature06731","volume":"452","author":"J Lim","year":"2008","unstructured":"Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, Hill DE, Orr HT, Zoghbi HY (2008) Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 452:713\u2013718","journal-title":"Nature"},{"key":"18_CR116","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1440-1789.2000.00354.x","volume":"20","author":"M Yamada","year":"2000","unstructured":"Yamada M, Tsuji S, Takahashi H (2000) Pathology of CAG repeat diseases. Neuropathology 20:319\u2013325","journal-title":"Neuropathology"},{"key":"18_CR117","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","volume":"96","author":"A Kazantsev","year":"1999","unstructured":"Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A 96:11404\u201311409","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR118","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1083\/jcb.143.6.1457","volume":"143","author":"MK Perez","year":"1998","unstructured":"Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, Pittman RN (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 143:1457\u20131470","journal-title":"J Cell Biol"},{"key":"18_CR119","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1523\/JNEUROSCI.2053-06.2006","volume":"26","author":"BO Evert","year":"2006","unstructured":"Evert BO, Araujo J, Vieira-Saecker AM, de Vos RA, Harendza S, Klockgether T, Wullner U (2006) Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J Neurosci 26:11474\u201311486","journal-title":"J Neurosci"},{"key":"18_CR120","doi-asserted-by":"crossref","first-page":"45004","DOI":"10.1074\/jbc.M205259200","volume":"277","author":"F Li","year":"2002","unstructured":"Li F, Macfarlan T, Pittman RN, Chakravarti D (2002) Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem 277:45004\u201345012","journal-title":"J Biol Chem"},{"key":"18_CR121","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/hmg\/ddr197","volume":"20","author":"J Araujo","year":"2011","unstructured":"Araujo J, Breuer P, Dieringer S, Krauss S, Dorn S, Zimmermann K, Pfeifer A, Klockgether T, Wuellner U, Evert BO (2011) FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. Hum Mol Genet 20:2928\u20132941","journal-title":"Hum Mol Genet"},{"key":"18_CR122","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","volume":"31","author":"AH Chou","year":"2008","unstructured":"Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL (2008) Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis 31:89\u2013101","journal-title":"Neurobiol Dis"},{"key":"18_CR123","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001","volume":"21","author":"BO Evert","year":"2001","unstructured":"Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, Brunt ER, Schmitt I, Klockgether T, Wullner U (2001) Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci 21:5389\u20135396","journal-title":"J Neurosci"},{"key":"18_CR124","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnen\/62.10.1006","volume":"62","author":"BO Evert","year":"2003","unstructured":"Evert BO, Vogt IR, Vieira-Saecker AM, Ozimek L, de Vos RA, Brunt ER, Klockgether T, Wullner U (2003) Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J Neuropathol Exp Neurol 62:1006\u20131018","journal-title":"J Neuropathol Exp Neurol"},{"key":"18_CR125","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ymthe.2017.01.021","volume":"25","author":"V Carmona","year":"2017","unstructured":"Carmona V, Cunha-Santos J, Onofre I, Sim\u00f5es AT, Vijayakumar U, Davidson BL, de Almeida Pereira (2017) Unravelling endogenous microRNA system dysfunction as a new pathophysiological mechanism in Mahcado-Joseph disease. Mol Ther 25:1028\u20131055","journal-title":"Mol Ther"},{"key":"18_CR126","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2007.03.160","volume":"357","author":"E Fei","year":"2007","unstructured":"Fei E, Jia N, Zhang T, Ma X, Wang H, Liu C, Zhang W, Ding L, Nukina N, Wang G (2007) Phosphorylation of ataxin-3 by glycogen synthase kinase 3 beta at serine 256 regulates the aggregation of ataxin-3. Biochem Biophys Res Commun 357:487\u2013492","journal-title":"Biochem Biophys Res Commun"},{"key":"18_CR127","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1093\/hmg\/ddp274","volume":"18","author":"T Mueller","year":"2009","unstructured":"Mueller T, Breuer P, Schmitt I, Walter J, Evert BO, Wullner U (2009) CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum Mol Genet 18:3334\u20133343","journal-title":"Hum Mol Genet"},{"issue":"4","key":"18_CR128","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1083\/jcb.201506025","volume":"212","author":"Carlos A. Matos","year":"2016","unstructured":"Matos CA, N\u00f3brega C, Louros SR, Almeida B, Ferreiro E, Valero J, Pereira de Almeida L, Macedo-Ribeiro S, Carvalho AL (2016) Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models. J Cell Biol 212(4):465\u2013480","journal-title":"The Journal of Cell Biology"},{"key":"18_CR129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/emboj.2008.289","volume":"28","author":"SV Todi","year":"2009","unstructured":"Todi SV, Winborn BJ, Scaglione KM, Blount JR, Travis SM, Paulson HL (2009) Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J 28:372\u2013382","journal-title":"EMBO J"},{"key":"18_CR130","doi-asserted-by":"crossref","first-page":"39303","DOI":"10.1074\/jbc.M110.181610","volume":"285","author":"SV Todi","year":"2010","unstructured":"Todi SV, Scaglione KM, Blount JR, Basrur V, Conlon KP, Pastore A, Elenitoba-Johnson K, Paulson HL (2010) Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117. J Biol Chem 285:39303\u201339313","journal-title":"J Biol Chem"},{"key":"18_CR131","doi-asserted-by":"crossref","first-page":"34460","DOI":"10.1074\/jbc.M113.513903","volume":"288","author":"WL Tsou","year":"2013","unstructured":"Tsou WL, Burr AA, Ouyang M, Blount JR, Scaglione KM, Todi SV (2013) Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo. J Biol Chem 288:34460\u201334469","journal-title":"J Biol Chem"},{"key":"18_CR132","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.bbadis.2015.06.010","volume":"1852","author":"B Almeida","year":"2015","unstructured":"Almeida B, Abreu IA, Matos CA, Fraga JS, Fernandes S, Macedo MG, Gutierrez-Gallego R, Pereira PJ, Carvalho AL, Macedo-Ribeiro S (2015) SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97. Biochim Biophys Acta 1852:1950\u20131959","journal-title":"Biochim Biophys Acta"},{"key":"18_CR133","doi-asserted-by":"crossref","first-page":"e54214","DOI":"10.1371\/journal.pone.0054214","volume":"8","author":"YF Zhou","year":"2013","unstructured":"Zhou YF et al (2013) SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity. PLoS ONE 8:e54214","journal-title":"PLoS ONE"},{"key":"18_CR134","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mad.2008.11.006","volume":"130","author":"T Farooqui","year":"2009","unstructured":"Farooqui T, Farooqui AA (2009) Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130:203\u2013215","journal-title":"Mech Ageing Dev"},{"key":"18_CR135","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194\u20131217","journal-title":"Cell"},{"key":"18_CR136","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S1357-2725(02)00085-7","volume":"34","author":"G Carrard","year":"2002","unstructured":"Carrard G, Bulteau AL, Petropoulos I, Friguet B (2002) Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 34:1461\u20131474","journal-title":"Int J Biochem Cell Biol"},{"key":"18_CR137","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1096\/fj.04-2578fje","volume":"19","author":"DA Ferrington","year":"2005","unstructured":"Ferrington DA, Husom AD, Thompson LV (2005) Altered proteasome structure, function, and oxidation in aged muscle. FASEB J 19:644\u2013646","journal-title":"FASEB J"},{"key":"18_CR138","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.biocel.2004.05.003","volume":"36","author":"JN Keller","year":"2004","unstructured":"Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q (2004) Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol 36:2376\u20132391","journal-title":"Int J Biochem Cell Biol"},{"key":"18_CR139","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/iub.46","volume":"60","author":"A Boveris","year":"2008","unstructured":"Boveris A, Navarro A (2008) Brain mitochondrial dysfunction in aging. IUBMB Life 60:308\u2013314","journal-title":"IUBMB Life"},{"key":"18_CR140","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1091\/mbc.E10-07-0654","volume":"22","author":"KH Chang","year":"2011","unstructured":"Chang KH et al (2011) Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Mol Biol Cell 22:1452\u20131462","journal-title":"Mol Biol Cell"},{"key":"18_CR141","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-0102(99)00026-7","volume":"34","author":"KY Lee","year":"1999","unstructured":"Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN (1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34:21\u201329","journal-title":"Neurosci Res"},{"key":"18_CR142","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-4159.2003.02328.x","volume":"88","author":"SB Shelton","year":"2004","unstructured":"Shelton SB, Johnson GV (2004) Cyclin-dependent kinase-5 in neurodegeneration. J Neurochem 88:1313\u20131326","journal-title":"J Neurochem"},{"key":"18_CR143","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08983","volume":"464","author":"NA Bishop","year":"2010","unstructured":"Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464:529\u2013535","journal-title":"Nature"},{"key":"18_CR144","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2005.01.027","volume":"120","author":"TB Kirkwood","year":"2005","unstructured":"Kirkwood TB (2005) Understanding the odd science of aging. Cell 120:437\u2013447","journal-title":"Cell"},{"key":"18_CR145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.1099196","volume":"305","author":"HY Cohen","year":"2004","unstructured":"Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390\u2013392","journal-title":"Science"},{"key":"18_CR146","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1038\/ncomms11445","volume":"7","author":"J Cunha-Santos","year":"2016","unstructured":"Cunha-Santos J, Duarte-Neves J, Carmona V, Guarente L, Pereira de Almeida L, Cavadas C (2016) Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway. Nat Commun 7:11445","journal-title":"Nat Commun"}],"container-title":["Advances in Experimental Medicine and Biology","Polyglutamine Disorders"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-71779-1_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:07Z","timestamp":1603843207000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-71779-1_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319717784","9783319717791"],"references-count":146,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-71779-1_18","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}